<DOC>
	<DOCNO>NCT00126906</DOCNO>
	<brief_summary>In Malawi , standard care prevent malaria pregnancy time study two dose sulfadoxine-pyrimethamine intermittent protective treatment ( SP IPT ) regimen administer second third trimester pregnancy . In investigation , two dose strategy compare monthly SP regimen . The objective study determine efficacy different regimen HIV positive HIV negative woman prevention placental malaria .</brief_summary>
	<brief_title>Prevention Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine : Malawi</brief_title>
	<detailed_description>In protocol researcher wish elaborate prior investigation factor may affect prevalence malarial parasite density pregnant woman Malawi . Primarily , investigation evaluate efficacy current Malawian national policy , sulfadoxine-pyrimethamine ( SP ) 2-dose intermittent protective treatment ( IPT ) strategy , compare monthly SP strategy use prevent malaria pregnancy . Previous investigation Malawi demonstrate : prevention malaria pregnancy important first second pregnancy , particularly rainy season malaria transmission high ; efficacious antimalarial regimen clear parasitemia placental infection result reduction incidence low birth weight , single great risk factor neonatal early infant mortality . There appear interaction HIV infection placental malaria , HIV-positive pregnant woman higher prevalence densities peripheral placental parasitemia compare HIV-negative pregnant woman . This finding require close examination , light high prevalence incidence HIV infection Malawi African country . Previously Malawi , 2-dose IPT regimen SP administer second third trimester pregnancy effective clearing placental malaria infection delivery More recent study Malawi Kenya show 2 dos may adequate clear placental parasitemia especially woman HIV infect . In Kenya study , HIV-positive woman require 3 dos SP ( deliver monthly dose scheme ) achieve similar reduction placental parasitemia see HIV-negative woman 2 dos . There remain need identify optimal dose schedule intermittent treatment regimen ; Kenya finding need confirm decision make national global level . This especially important give possibility increase SP resistance Malawi . The question HIV infection role malaria pregnancy , term impact regimen effectiveness incidence adverse sulfa reaction need examine . This study propose determine efficacy current regimen 2-dose SP intermittent protective treatment ( IPT ) compare monthly SP dose clear placental parasitemia delivery Machinga district Malawi high level malaria transmission HIV seropositivity rate nearly 20 % reproductive age woman . This study also explore effect HIV seropositivity safety efficacy intermittent preventive treatment pregnancy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>First second pregnancy Greater 16 week gestation Less 28 week gestation Consent HIV test Less 15 year old</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>HIV</keyword>
</DOC>